Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Sep 14

PMID 39272877

Authors

Thomas Bazin

Karine Nozeret

Catherine Julie

Dominique Lamarque

Eliette Touati

Affiliations

Soon will be listed here.

Abstract

Gastric cancer (GC) is a major cause of cancer-related mortality worldwide. It is often associated with a bad prognosis because of its asymptomatic phenotype until advanced stages, highlighting the need for its prevention and early detection. GC development is preceded by the emergence of gastric preneoplasia lesions (GPNLs), namely atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia (DYS). GC is currently diagnosed by endoscopy, which is invasive and costly and has limited effectiveness for the detection of GPNLs. Therefore, the discovery of non-invasive biomarkers in liquid biopsies, such as blood samples, in order to identify the presence of gastric preneoplasia and/or cancer lesions at asymptomatic stages is of paramount interest. This comprehensive review provides an overview of recently identified plasma/serum proteins and their diagnostic performance for the prediction of GPNLs and early cancer lesions. Autoantibodies appear to be promising biomarkers for AG, IM and early gastric cancer detection, along with inflammation and immunity-related proteins and antibodies against virulence factors. There is a lack of specific protein biomarkers with which to detect DYS. Despite the need for further investigation and validation, some emerging candidates could pave the way for the development of reliable, non-invasive diagnostic tests for the detection and prevention of GC.

References

Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I . Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011; 141(6):2017-2025.e3. DOI: 10.1053/j.gastro.2011.08.007. View

Miyaoka M, Yao K, Tanabe H, Kanemitsu T, Otsu K, Imamura K . Diagnosis of early gastric cancer using image enhanced endoscopy: a systematic approach. Transl Gastroenterol Hepatol. 2020; 5:50. PMC: 7530321. DOI: 10.21037/tgh.2019.12.16. View

Meistere I, Werner S, Zayakin P, Silina K, Rulle U, Pismennaja A . The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions. Cancer Epidemiol Biomarkers Prev. 2017; 26(10):1564-1574. DOI: 10.1158/1055-9965.EPI-17-0238. View

Wang H, Jin W, Wan C, Zhu C . Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72-4 alone in gastric cancer: a systematic review and meta-analysis. Transl Cancer Res. 2022; 11(4):848-856. PMC: 9091039. DOI: 10.21037/tcr-22-537. View

den Hollander W, Holster I, den Hoed C, Capelle L, Tang T, Anten M . Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2018; 68(4):585-593. DOI: 10.1136/gutjnl-2017-314498. View

Bizzaro N, Antico A, Villalta D . Autoimmunity and Gastric Cancer. Int J Mol Sci. 2018; 19(2). PMC: 5855599. DOI: 10.3390/ijms19020377. View

Dayon L, Cominetti O, Affolter M . Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications. Expert Rev Proteomics. 2022; 19(2):131-151. DOI: 10.1080/14789450.2022.2070477. View

Kanda M, Suh Y, Park D, Tanaka C, Ahn S, Kong S . Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer. 2019; 23(2):203-211. DOI: 10.1007/s10120-019-00995-z. View

Yoo M, Park J, Han H, Yun Y, Kang J, Choi D . Discovery of gastric cancer specific biomarkers by the application of serum proteomics. Proteomics. 2017; 17(6). DOI: 10.1002/pmic.201600332. View

10.

Amedei A, Bergman M, Appelmelk B, Azzurri A, Benagiano M, Tamburini C . Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003; 198(8):1147-56. PMC: 2194239. DOI: 10.1084/jem.20030530. View

11.

Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K . Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch. 2014; 464(4):403-7. DOI: 10.1007/s00428-014-1544-3. View

12.

Li L, Dong J, Fu L, Xia X, Pan F, Ning Y . Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer. J Oncol. 2021; 2021:2483964. PMC: 8516522. DOI: 10.1155/2021/2483964. View

13.

Jeong S, Oh M, Kim U, Lee J, Kim J, An H . Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians. Expert Rev Proteomics. 2020; 17(2):109-117. DOI: 10.1080/14789450.2020.1740091. View

14.

Choi B, Lee H, Min J, Choe H, Choi Y, Son Y . Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer. Cancer Biomark. 2017; 19(3):231-239. DOI: 10.3233/CBM-160147. View

15.

Romanczyk M, Osmola M, Link A, Druet A, Hemont C, Martin J . Non-Invasive Markers for the Detection of Gastric Precancerous Conditions. Cancers (Basel). 2024; 16(12). PMC: 11202181. DOI: 10.3390/cancers16122254. View

16.

Shen Q, Polom K, Williams C, Marques Souza de Oliveira F, Guergova-Kuras M, Lisacek F . A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer. EBioMedicine. 2019; 44:322-333. PMC: 6606959. DOI: 10.1016/j.ebiom.2019.05.044. View

17.

Lahner E, Marzinotto I, Lampasona V, Dottori L, Bazzigaluppi E, Brigatti C . Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis. Clin Transl Gastroenterol. 2020; 11(10):e00240. PMC: 7544173. DOI: 10.14309/ctg.0000000000000240. View

18.

Aleksandrova K, Chuang S, Boeing H, Zuo H, Tell G, Pischon T . A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk. J Natl Cancer Inst. 2015; 107(4). PMC: 4402364. DOI: 10.1093/jnci/djv010. View

19.

Pan K, Formichella L, Zhang L, Zhang Y, Ma J, Li Z . Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int J Cancer. 2013; 134(9):2118-25. DOI: 10.1002/ijc.28560. View

20.

Yoon J, Park Y, Nam S, Park W . The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer. Cancer Med. 2019; 8(12):5507-5514. PMC: 6745860. DOI: 10.1002/cam4.2457. View